Home » News, Vaccines

Menveo – a new meningitis vaccine available in Europe for the first time

31 March 2010 Email This Post Email This Post Print This Post Print This Post

Syringe VaccineMenveo, a new meningitis vaccine, is available in Europe for the first time. The vaccine protects against four major strains of the disease and could be used as a travel vaccine to protect people who travel in sub-Saharan Africa.

Menveo can protect people who have not been vaccinated and will offer longer lasting protection against the disease.  According to Dr. Jane Zukerman at the University College London Medical School: “Travellers should consider visiting a specialist travel health centre where they can be advised and provided with expert knowledge on the diseases they might be exposed to and the vaccines and medicines they require to keep well.”

Menveo, made by Novartis Vaccine and Diagnostics, has a licence for use in people over the age of 11 and it offers better protection against meningitis in infants and young children.

1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)

Leave your response!

Add your comment below, or trackback from your own site. You can also subscribe to these comments via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:
<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

This is a Gravatar-enabled weblog. To get your own globally-recognized-avatar, please register at Gravatar.